We first explored the immunological status of MARCH3 in HCC, and we observed that MARCH3 expression was positively associated with many of immunomodulators including immunoinhibitor, immunostimulator, major histocompatibility complex (MHC), chemokine and receptor. Here, MARCHF3 is linked to hepatocellular carcinoma.